Labcyte Introduces New 384-Well Low Dead Volume Microplate for Echo® 525 Liquid Handlers
Plate allows for smaller sample volumes and lower reaction costs
September 14, 2017
SAN JOSE, CA
Labcyte Inc., a company revolutionizing life science research with its patented acoustic liquid handling technology, today announced the release of a new 384-well low dead volume microplate for its Echo 525 Liquid Handlers. The new Echo Qualified 384 LDV Plus Microplate reduces the amount of sample or reagent required in a well for transfer by 75% or more.
Labcyte’s Echo 525 Liquid Handlers use focused sound energy to dispense precisely sized 25nL droplets of samples or reagents from microplate to microplate without the contact of tips or nozzles. Larger volume transfers are achieved by transferring several hundred droplets per second. This reduces costs by allowing miniaturization and leads to improved results by eliminating the contamination risks associated with tips.
The speed at which Echo systems transfer fluid from any well on a microplate to any well on another microplate has driven its adoption for pooling in synthetic biology and genomics applications where DNA oligos, sequencing libraries and PCR primers are pooled in random combinations. With the ability to miniaturize reaction volumes while improving experimental outcomes, Echo system users in academic institutions as well as industrial biotechnology and pharmaceutical companies experience immediate improvements in efficiency and productivity.
“The Echo 525 Liquid Handler has proven to dramatically reduce the costs and time of sample preparation for core labs, DNA foundries and synthetic biology organizations that rely on automated liquid handling to prepare samples for a wide range of experiments,” said Chris Grimley, Labcyte’s Vice President of Marketing. “Our new plate with a lower dead volume requirement will give customers higher cost savings with every experiment. This is especially helpful for customers performing miniaturized reactions for next-generation sequencing library preparation and PCR assays.”
About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, as well as by biotechnology companies, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 60 U.S. patents and others internationally. For more information, visit www.labcyte.com.
- PR Contact:
- Nicole Litchfield
- Bioscribe, Inc.